Papers on elevated Lp

122 papers37 new in 30 days

Friday, October 9

Journal of Cardiovascular PharmacologyOct 9

Targeting Lipoprotein(a) in Cardiovascular Disease: Emerging Therapies and Clinical Implications

ReviewAtherosclerotic cardiovascular disease

Paper

Thursday, October 8

Journal of Atherosclerosis and ThrombosisOct 8

Lipoprotein(a) is Independently Associated with Polyvascular Disease Burden

Cohort study of 1,799 peopleLipoprotein

Paper

Wednesday, October 7

JACC AsiaOct 7

Elevated Lipoprotein(a) in Asian Populations and its Implications for Cardiovascular Disease

Systematic review of observational studiesLipoprotein

Paper

European Journal of Preventive CardiologyOct 7

Lipoprotein(a) and the continuum of carotid atherosclerosis from plaque initiation to luminal stenosis: the Suita Study

Cohort study of 3,272 peopleCarotid artery stenosis

Paper

Journal of Clinical LipidologyOct 7

Efficacy and tolerability of targeted lipoprotein(a)-lowering therapies: A systematic review

Systematic reviewInterventions

Paper

Tuesday, October 6

Frontiers in Cardiovascular MedicineOct 6

Lp(a), platelet count, aspirin and cardiovascular outcome: a prospective cohort analysis

Schematic summary of the study design and main findings.

Cohort study of 250,927 peoplePlatelet count

Paper

Friday, October 2

Frontiers in Cardiovascular MedicineOct 2

Lipoprotein(a) levels and estimated QRISK3 cardiovascular risk in the Randox Health 2025 cohort: a cross-sectional analysis of 14,848 individuals

Cross-sectional study of 14,848 peopleQRISK3

Paper

Saturday, September 26

BiomedicinesSep 26

Associations of Elevated Lipoprotein(a) with C-Reactive Protein and Type 2 Diabetes in a Multiethnic Population

Circulation levels of Lp(a) in the entire study population stratified by (a). gender, (b). ethnicity, and (c). diabetes status.

Cross-sectional study of 2,083 peopleType 2 diabetes

Paper

Monday, September 21

CureusSep 21

Lipoprotein(a) as a Predictor of Major Adverse Cardiovascular Events: A Systematic Review and Meta-Analysis of Cohort Studies (2016-2026)

PRISMA 2020 flow diagram of study identification, screening, and inclusion.

Meta-analysis of observational studiesLipoprotein

Paper

Saturday, September 19

Nutrition, Metabolism, and Cardiovascular DiseasesSep 19

Association of lipoprotein(a) and MASLD in predicting carotid atherosclerosis in asymptomatic individuals: a large scale cross-sectional and longitudinal study

Cohort study of 61,139 peopleCarotid atherosclerosis

Paper

Methodist DeBakey Cardiovascular JournalSep 19

Targeting Lipoprotein(a): A New Era in Cardiovascular Disease Prevention

ReviewAtherosclerotic cardiovascular disease

Paper

International Journal of General MedicineSep 19

Elevated Lipoprotein(a) is Independently Associated with Deep Cerebral Microbleeds in Patients with Chronic Kidney Disease: A Retrospective Observational Study

Flow chart of participant screening in this study.

Cohort study of 137 peopleLipoprotein

Paper

Friday, September 18

CJC OpenSep 18

Rationale and Design of the Canadian Lipoprotein(a) Registry

Cohort study of 127 peoplePopulations

Paper

Friday, September 11

Journal of Clinical LipidologySep 11

Integration of lipoprotein(a) testing into inpatient cardiology-lipid clinic pathway: A 2-year review of LILAC heart initiative using RE-AIM framework

Cohort study of 3,191 peopleInterventions

Paper

Journal of Clinical LipidologySep 11

Lipoprotein(a) and subclinical atherosclerosis

ReviewLipoprotein

Paper

Monday, September 7

Journal of Clinical LipidologySep 7

Elevated lipoprotein(a) and prevalent cardiovascular disease burden in treated hypertension

Cross-sectional study of 2,313 peopleLipoprotein

Paper

Diabetes, Metabolic Syndrome and ObesitySep 7

Prevalence of Elevated Lipoprotein(a) and Its Association with Cardiovascular Disease in Patients with Overweight and Obesity in Argentina

Cross-sectional study of 2,975 peopleLipoprotein

Paper

Sunday, September 6

Frontiers in Cardiovascular MedicineSep 6

The impact of lipoprotein(a) determination in cardiovascular risk stratification among people living with HIV

Cross-sectional study of 69 peopleLipoprotein

Paper

Thursday, September 3

Australian Journal of General PracticeSep 3

Lipoprotein(a): Actionable today, treatable tomorrow?

ReviewLipoprotein

Paper

Tuesday, September 1

Frontiers in MedicineSep 1

Beyond lipids: a precision prevention blueprint for China's residual risk

An integrated multimodal framework for residual-risk assessment and precision prevention in Chinese ASCVD.

CommentaryBiomarkers

Paper

American Journal of Cardiovascular DrugsSep 1

Lipoprotein(a): Cardiovascular Risk and Emerging Targeted Therapies

ReviewAtherosclerotic cardiovascular disease

Paper

Thursday, August 27

MedicinaAug 27

Lipoprotein(a) and Hypertension-Mediated Organ Damage in Patients with Essential Hypertension: Associations with Carotid Plaque and Impaired Nocturnal Blood Pressure Dipping

Correlation between serum Lp(a) concentration and nocturnal systolic blood pressure dipping percentage.

Cross-sectional study of 80 peopleLipoprotein

Paper

Journal of Clinical MedicineAug 27

Lipoprotein(a) Levels and Embolic Stroke of Undetermined Source in Patients with Patent Foramen Ovale

Case-control study in peopleLipoprotein

Paper

BiomedicinesAug 27

Lipoprotein(a) as a Cardiovascular Risk Factor: Clinical Significance and Therapeutic Perspectives

ReviewInterventions

Paper

Wednesday, August 26

PLOS OneAug 26

The burden of Lipoprotein(a) [Lp(a)] in Africa: A systematic review

Systematic review of observational studiesPopulations

Paper

Frontiers in MedicineAug 26

Lipoprotein(a) in cardiovascular disease: pathophysiology, residual risk, and emerging therapeutic strategies

ReviewAtherosclerotic cardiovascular disease

Paper

Tuesday, August 25

AtherosclerosisAug 25

The hidden atherogenic burden of lipoprotein(a): Reclassification by risk-weighted apoB in a multicenter registry

Cohort study of 1,861 peopleTriglyceride-rich lipoproteins

Paper

Monday, August 24

Current Opinion in LipidologyAug 24

Lipoprotein(a): a unique lipoprotein at the crossroads of atherosclerosis and thrombosis

ReviewMechanisms

Paper

Thursday, August 13

Journal of Clinical MedicineAug 13

Independent and Joint Associations of Lipoprotein(a) and Homocysteine with Carotid-Femoral Pulse-Wave Velocity in Adults with Treated Hypertension: A Single-Centre Cross-Sectional Study

Association between lipoprotein(a) and carotid–femoral pulse-wave velocity.

Cross-sectional study of 366 peopleCarotid-femoral pulse wave velocity

Paper

Journal of Clinical MedicineAug 13

Lipoprotein(a) in Coronary Artery Disease and Aortic Stenosis: Pathophysiology, Clinical Impact, Interventional Implications and Emerging Targeted Therapies

Structural composition, metabolism, and biological function of Lipoprotein(a).

ReviewMechanisms

Paper